California Public Employees Retirement System Albireo Pharma, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$28.9 - $36.87 $783,190 - $999,176	-27,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$32.03 - $42.85 $102,367 - $136,948	-3,196 Reduced 10.55%	27,100 $955,000
Q4 2020 Feb 02, 2021	BUY	$31.56 - $42.16 $81,929 - $109,447	2,596 Added 9.37%	30,296 $1.14 Million
Q3 2020 Nov 05, 2020	BUY	$23.19 - $41.61 $18,552 - $33,288	800 Added 2.97%	27,700 $924,000
Q2 2020 Aug 12, 2020	BUY	$14.82 - $29.92 $138,492 - $279,602	9,345 Added 53.23%	26,900 $713,000
Q4 2019 Jan 27, 2020	BUY	$16.92 - $28.96 $297,030 - $508,392	17,555 New	17,555 $446,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account